Publication:
New causes of hypophysitis

dc.contributor.authorYuen, Kevin C.J. (7202333713)
dc.contributor.authorPopovic, Vera (57294508600)
dc.contributor.authorTrainer, Peter J. (56355462700)
dc.date.accessioned2025-06-12T15:12:46Z
dc.date.available2025-06-12T15:12:46Z
dc.date.issued2019
dc.description.abstractHypophysitis is a rare entity characterized by inflammation of the pituitary gland and its stalk that can cause hypopituitarism and/or mass effect. Etiology can be categorized as primary or secondary to systemic disease, but may also be classified according to anatomical and hispathological criteria. Newly recognized causes of hypophysits have been described, mainly secondary to immunomodulatory medications and IgG4-related disease. Diagnosis is based on clinical, laboratory and imaging data, whereas pituitary biopsy, though rarely indicated, may provide a definitive histological diagnosis. For the clinician, obtaining a broad clinical and drug history, and performing a thorough physical examination is essential. Management of hypophysitis includes hormone replacement therapy if hypopituitarism is present and control of the consequences of the inflammatory pituitary mass (e.g. compression of the optic chiasm) using high-dose glucocorticoids, whereas pituitary surgery is reserved for those unresponsive to medical therapy and/or have progressive disease. However, there remains an unmet need for controlled studies to inform clinical practice. © 2019 Elsevier Ltd
dc.identifier.urihttps://doi.org/10.1016/j.beem.2019.04.010
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85065231116&doi=10.1016%2fj.beem.2019.04.010&partnerID=40&md5=8d92e5a0f206dbb325e44047fea2ef41
dc.identifier.urihttps://remedy.med.bg.ac.rs/handle/123456789/5579
dc.subjectautoimmune
dc.subjecthypophysitis
dc.subjectIgG4-related disease
dc.subjectIgG4-related hypophysitis
dc.subjectimmune checkpoint inhibitor
dc.subjectipilimumab
dc.titleNew causes of hypophysitis
dspace.entity.typePublication

Files